Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-26
DOI
10.1111/head.13823
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The REDCap consortium: Building an international community of software platform partners
- (2019) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats
- (2019) Agustin Melo-Carrillo et al. CEPHALALGIA
- Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes
- (2017) Andrew M. Blumenfeld et al. HEADACHE
- Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
- (2016) XiChun Zhang et al. CEPHALALGIA
- Botulinum toxin-a treatment reduces human mechanical pain sensitivity and mechanotransduction
- (2014) Kathryn Paterson et al. ANNALS OF NEUROLOGY
- Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
- (2014) Rami Burstein et al. CEPHALALGIA
- OnabotulinumtoxinA for the Treatment of Headache
- (2013) Avi Ashkenazi et al. HEADACHE
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
- (2011) Sheena K. Aurora et al. HEADACHE
- Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study
- (2011) A.T. Güleç JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
- (2010) Andrew Blumenfeld et al. HEADACHE
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis
- (2010) Parisa Gazerani et al. PAIN
- FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products
- (2009) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
- (2008) Parisa Gazerani et al. PAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More